Across TCGA pan-cancer cohorts, MIR5579 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR5579’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where MIR5579 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR5579 is over-expressed in tumor.
LUAD are the cancer types where MIR5579 tumor–normal differential expression is most reproducible.